UniProt ID | RRP15_HUMAN | |
---|---|---|
UniProt AC | Q9Y3B9 | |
Protein Name | RRP15-like protein | |
Gene Name | RRP15 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 282 | |
Subcellular Localization | ||
Protein Description | ||
Protein Sequence | MAAAAPDSRVSEEENLKKTPKKKMKMVTGAVASVLEDEATDTSDSEGSCGSEKDHFYSDDDAIEADSEGDAEPCDKENENDGESSVGTNMGWADAMAKVLNKKTPESKPTILVKNKKLEKEKEKLKQERLEKIKQRDKRLEWEMMCRVKPDVVQDKETERNLQRIATRGVVQLFNAVQKHQKNVDEKVKEAGSSMRKRAKLISTVSKKDFISVLRGMDGSTNETASSRKKPKAKQTEVKSEEGPGWTILRDDFMMGASMKDWDKESDGPDDSRPESASDSDT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAAAPDSR ------CCCCCCCCC | 13.05 | 21406692 | |
8 | Phosphorylation | MAAAAPDSRVSEEEN CCCCCCCCCCCHHHH | 33.26 | 23401153 | |
9 | Citrullination | AAAAPDSRVSEEENL CCCCCCCCCCHHHHH | 43.28 | - | |
9 | Citrullination | AAAAPDSRVSEEENL CCCCCCCCCCHHHHH | 43.28 | - | |
11 | Phosphorylation | AAPDSRVSEEENLKK CCCCCCCCHHHHHHC | 37.87 | 29255136 | |
17 | Acetylation | VSEEENLKKTPKKKM CCHHHHHHCCCHHHH | 67.21 | 25953088 | |
19 | Phosphorylation | EEENLKKTPKKKMKM HHHHHHCCCHHHHHH | 38.46 | 26055452 | |
33 | Phosphorylation | MVTGAVASVLEDEAT HHHHHHHHHHHCCCC | 22.19 | 20873877 | |
40 | Phosphorylation | SVLEDEATDTSDSEG HHHHCCCCCCCCCCC | 37.45 | 28348404 | |
42 | Phosphorylation | LEDEATDTSDSEGSC HHCCCCCCCCCCCCC | 30.03 | 28348404 | |
43 | Phosphorylation | EDEATDTSDSEGSCG HCCCCCCCCCCCCCC | 41.78 | 28348404 | |
45 | Phosphorylation | EATDTSDSEGSCGSE CCCCCCCCCCCCCCC | 43.56 | 28348404 | |
48 | Phosphorylation | DTSDSEGSCGSEKDH CCCCCCCCCCCCCCC | 15.97 | 20873877 | |
51 | Phosphorylation | DSEGSCGSEKDHFYS CCCCCCCCCCCCCCC | 45.89 | 25159151 | |
57 | Phosphorylation | GSEKDHFYSDDDAIE CCCCCCCCCCCHHCC | 14.05 | 22617229 | |
58 | Phosphorylation | SEKDHFYSDDDAIEA CCCCCCCCCCHHCCC | 33.35 | 26503892 | |
67 | Phosphorylation | DDAIEADSEGDAEPC CHHCCCCCCCCCCCC | 50.99 | 26503892 | |
84 | Phosphorylation | ENENDGESSVGTNMG CCCCCCCCCCCCHHH | 35.53 | 25159151 | |
85 | Phosphorylation | NENDGESSVGTNMGW CCCCCCCCCCCHHHH | 21.92 | 28985074 | |
88 | Phosphorylation | DGESSVGTNMGWADA CCCCCCCCHHHHHHH | 21.63 | 27251275 | |
102 | Acetylation | AMAKVLNKKTPESKP HHHHHHCCCCCCCCC | 54.59 | 7340243 | |
103 | Acetylation | MAKVLNKKTPESKPT HHHHHCCCCCCCCCE | 69.14 | 7340253 | |
104 | Phosphorylation | AKVLNKKTPESKPTI HHHHCCCCCCCCCEE | 33.62 | 29255136 | |
107 | Phosphorylation | LNKKTPESKPTILVK HCCCCCCCCCEEEEE | 45.17 | 25159151 | |
108 | Sumoylation | NKKTPESKPTILVKN CCCCCCCCCEEEEEC | 44.51 | 28112733 | |
108 | Acetylation | NKKTPESKPTILVKN CCCCCCCCCEEEEEC | 44.51 | 23954790 | |
108 | Ubiquitination | NKKTPESKPTILVKN CCCCCCCCCEEEEEC | 44.51 | 33845483 | |
110 | Phosphorylation | KTPESKPTILVKNKK CCCCCCCEEEEECHH | 30.58 | 23927012 | |
114 | Acetylation | SKPTILVKNKKLEKE CCCEEEEECHHHHHH | 60.65 | 26051181 | |
149 | Ubiquitination | WEMMCRVKPDVVQDK HHHHHCCCCCCCCCH | 19.02 | 29967540 | |
156 | Acetylation | KPDVVQDKETERNLQ CCCCCCCHHHHHHHH | 49.82 | 25953088 | |
156 | Ubiquitination | KPDVVQDKETERNLQ CCCCCCCHHHHHHHH | 49.82 | 24816145 | |
179 | Ubiquitination | QLFNAVQKHQKNVDE HHHHHHHHHHCCHHH | 41.21 | 23000965 | |
179 | Sumoylation | QLFNAVQKHQKNVDE HHHHHHHHHHCCHHH | 41.21 | 28112733 | |
179 | Acetylation | QLFNAVQKHQKNVDE HHHHHHHHHHCCHHH | 41.21 | 25953088 | |
182 | Ubiquitination | NAVQKHQKNVDEKVK HHHHHHHCCHHHHHH | 59.67 | 23000965 | |
193 | Phosphorylation | EKVKEAGSSMRKRAK HHHHHHHHHHHHHHH | 28.19 | 24732914 | |
194 | Phosphorylation | KVKEAGSSMRKRAKL HHHHHHHHHHHHHHH | 22.99 | 24732914 | |
200 | Acetylation | SSMRKRAKLISTVSK HHHHHHHHHHHHCCH | 50.84 | 25953088 | |
200 | Ubiquitination | SSMRKRAKLISTVSK HHHHHHHHHHHHCCH | 50.84 | 33845483 | |
203 | Phosphorylation | RKRAKLISTVSKKDF HHHHHHHHHCCHHHH | 32.94 | 26434776 | |
204 | Phosphorylation | KRAKLISTVSKKDFI HHHHHHHHCCHHHHH | 23.08 | 28387310 | |
206 | Phosphorylation | AKLISTVSKKDFISV HHHHHHCCHHHHHHH | 33.79 | 26434776 | |
207 | Ubiquitination | KLISTVSKKDFISVL HHHHHCCHHHHHHHH | 52.61 | 23000965 | |
207 | 2-Hydroxyisobutyrylation | KLISTVSKKDFISVL HHHHHCCHHHHHHHH | 52.61 | - | |
207 | Acetylation | KLISTVSKKDFISVL HHHHHCCHHHHHHHH | 52.61 | 25953088 | |
208 | Ubiquitination | LISTVSKKDFISVLR HHHHCCHHHHHHHHC | 50.82 | 23000965 | |
208 | Sumoylation | LISTVSKKDFISVLR HHHHCCHHHHHHHHC | 50.82 | 28112733 | |
208 | Acetylation | LISTVSKKDFISVLR HHHHCCHHHHHHHHC | 50.82 | 91183 | |
212 | Phosphorylation | VSKKDFISVLRGMDG CCHHHHHHHHCCCCC | 18.32 | 28387310 | |
220 | Phosphorylation | VLRGMDGSTNETASS HHCCCCCCCCCCHHH | 24.64 | 29255136 | |
221 | Phosphorylation | LRGMDGSTNETASSR HCCCCCCCCCCHHHC | 42.47 | 29255136 | |
224 | Phosphorylation | MDGSTNETASSRKKP CCCCCCCCHHHCCCC | 33.63 | 29255136 | |
226 | Phosphorylation | GSTNETASSRKKPKA CCCCCCHHHCCCCCC | 37.79 | 29255136 | |
227 | Phosphorylation | STNETASSRKKPKAK CCCCCHHHCCCCCCC | 45.73 | 25262027 | |
234 | Ubiquitination | SRKKPKAKQTEVKSE HCCCCCCCCCCCCCC | 64.97 | 22817900 | |
239 | Sumoylation | KAKQTEVKSEEGPGW CCCCCCCCCCCCCCC | 46.01 | 25114211 | |
239 | Ubiquitination | KAKQTEVKSEEGPGW CCCCCCCCCCCCCCC | 46.01 | 22817900 | |
239 | Sumoylation | KAKQTEVKSEEGPGW CCCCCCCCCCCCCCC | 46.01 | - | |
240 | Phosphorylation | AKQTEVKSEEGPGWT CCCCCCCCCCCCCCE | 46.16 | 21815630 | |
258 | Phosphorylation | DDFMMGASMKDWDKE CCCCCCCCCCCCCCC | 22.19 | 21815630 | |
266 | Phosphorylation | MKDWDKESDGPDDSR CCCCCCCCCCCCCCC | 54.32 | 21082442 | |
272 | Phosphorylation | ESDGPDDSRPESASD CCCCCCCCCCCCCCC | 58.05 | 23927012 | |
276 | Phosphorylation | PDDSRPESASDSDT- CCCCCCCCCCCCCC- | 35.44 | 25159151 | |
278 | Phosphorylation | DSRPESASDSDT--- CCCCCCCCCCCC--- | 47.10 | 25159151 | |
280 | Phosphorylation | RPESASDSDT----- CCCCCCCCCC----- | 40.43 | 28355574 | |
282 | Phosphorylation | ESASDSDT------- CCCCCCCC------- | 44.45 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RRP15_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RRP15_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RRP15_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
DDX27_HUMAN | DDX27 | physical | 26344197 | |
DDX54_HUMAN | DDX54 | physical | 26344197 | |
MK67I_HUMAN | NIFK | physical | 26344197 | |
PK1IP_HUMAN | PAK1IP1 | physical | 26344197 | |
RBM28_HUMAN | RBM28 | physical | 26344197 | |
RPF2_HUMAN | RPF2 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-11, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-67; THR-104;SER-107 AND SER-226, ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, ANDMASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-11, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-104; SER-266; SER-276;SER-278 AND SER-280, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-67; THR-104;SER-107 AND SER-226, ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND MASSSPECTROMETRY. |